Doctor Mahendra Sibartie

Amgen, Uxbridge (United Kingdom of Great Britain & Northern Ireland)

Follow

Contributor content

High long-term persistence to evolocumab treatment regimens in European clinical practice: analysis of the HEYMANS registry

Presentation

High long-term persistence to evolocumab treatment regimens in European clinical practice: analysis of the HEYMANS registry

ESC 365 is supported by

novartis

Explore sponsored resources